Status:

UNKNOWN

National Registry of Adult Heart Failure Patients With Complex Congenital Heart Disease: Systemic Right Ventricle and Single Ventricle Treated With Sacubitril/Valsartan

Lead Sponsor:

University Hospital, Grenoble

Conditions:

Complex Congenital Heart Disease

Eligibility:

All Genders

18+ years

Brief Summary

Heart failure in adults with congenital heart disease is a major cause of morbidity and mortality. Patients with systemic right ventricle (SRV) and single ventricle (SV) are particularly at risk1, 2, ...

Eligibility Criteria

Inclusion

  • \- Patients ≥ 18 years of age
  • Congenital heart disease with systemic right ventricle (D-TGV after atrial switch (Mustard or Senning surgery) or double mismatch), single ventricle of right or left morphology
  • Systemic ventricular ejection fraction ≤ 40% (on cardiac magnetic resonance imaging (MRI) less than 12 months old).
  • In case of contraindication to MRI, LVEF ≤ 40% if systemic left ventricle or surface shortening fraction ≤ 35% if VDS12 (examination less than 12 months old).
  • NYHA II or III
  • On optimal heart failure therapy: ACE inhibitor or ARB2 for ≥ 4 weeks, at maximum tolerated dose. Whether or not combined with beta-blockers and maximum-tolerated-dose mineralocorticoid receptor antagonists.
  • Cardiopulmonary exercise test (CPET) within the last 12 months

Exclusion

  • \- Other congenital heart disease
  • Inability to perform CPETH
  • Immuno-allergic reaction, history of angioedema on ACE inhibitors or ARB2 inhibitors
  • Symptomatic arterial hypotension or BPs \< 100 mHg
  • Renal insufficiency (GFR \<30 mL/min/m²), hyperkalemia \> 5.4 mmol/l, severe hepatic insufficiency (Child-Pugh Class C)
  • Pregnancy or breast-feeding
  • Opposition to use of patient data
  • Type 1 diabetes if on iSGLT2

Key Trial Info

Start Date :

July 1 2021

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 1 2025

Estimated Enrollment :

50 Patients enrolled

Trial Details

Trial ID

NCT06149806

Start Date

July 1 2021

End Date

December 1 2025

Last Update

November 29 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Chu Grenoble Alpes

La Tronche, France, 38700